Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: kech who wrote (840)	7/19/1999 11:46:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2001

What keeps them from coming out with a SepraGel? Preclinical testing, formulation issues, patents (?), clinicals. There is a gel form of a hyaluronate-based product in development, however. It would be competitive with -A, and it's described in several posts to this thread. >> Are there other advantages of the ADCON product besides its gel form that would make it more successful in abdominal or pelvis surgeries compared to either the current SepraFilm or the possible arrival of a SepraGel? << We'll see. Phase III testing will tell us that.